All Stories

  1. Human Papillomavirus Testing and Size of CIN3: Implications for the Risk of Microinvasive Cervical Carcinoma
  2. Current practices in HPV-related anogenital neoplasia care in Europe – a survey analysis
  3. The challenging approach to the management of male partners of HPV-positive women
  4. Imiquimod for Anal High Grade Intraepithelial Neoplasia: A Systematic Review
  5. What Are Consumers Looking for With Boric Acid?
  6. Vulvar inspection at the time of cervical cancer screening: European Society of Gynaecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European ...
  7. Will artificial intelligence be the answer for the gap in vulvovaginal diseases?
  8. When did the confusion between vulvodynia and vaginismus start?
  9. Polymicrobial Consortia in the Pathogenesis of Biofilm Vaginosis Visualized by FISH. Historic Review Outlining the Basic Principles of the Polymicrobial Infection Theory
  10. Vulvar Inspection During Cervical Cancer Screening Procedures: The Ugly Reality
  11. Evaluation of Host Gene Methylation as a Triage Test for HPV–Positive Women—A Cohort Study
  12. Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
  13. The genital tract microbiome: bridging the gap between hype and clinical reality
  14. Genital tract microbiota composition profiles and use of prebiotics and probiotics in gynaecological cancer prevention: review of the current evidence, the European Society of Gynaecological Oncology prevention committee statement
  15. Is Vulvodynia Associated With an Altered Vaginal Microbiota?: A Systematic Review
  16. The International Society for the Study of Vulvovaginal Disease (ISSVD) Vulvar Awareness Day Campaign: Knowledge of Vulvovaginal Diseases Among Italian Obstetrics and Gynecology Residents
  17. Genital and extragenital oncological risk in women with vulvar lichen sclerosus: A multi-center Italian study
  18. Chlamydial and Gonococcal Genital Infections: A Narrative Review
  19. Low genitourinary tract risks in women living with the human immunodeficiency virus
  20. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) Consensus St...
  21. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus st...
  22. Vulvar High-Grade Squamous Intraepithelial Lesion and the Risk of Recurrence and Progression to Cancer
  23. Scoping review of cytolytic vaginosis literature
  24. International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis
  25. Chronic Hypertrophic Herpes Simplex Infection: A 13-Year Delay
  26. Therapeutic Options for Chlamydia trachomatis Infection: Present and Future
  27. Reply to De Giorgi et al. Comment on “Kesić et al. Early Diagnostics of Vulvar Intraepithelial Neoplasia. Cancers 2022, 14, 1822”
  28. Efficacy of Hormonal and Nonhormonal Approaches to Vaginal Atrophy and Sexual Dysfunctions in Postmenopausal Women: A Systematic Review
  29. Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream
  30. Vaginal Leptothrix: An Innocent Bystander?
  31. Changes in the Vaginal Microbiota of Women With Secondary Localized Provoked Vulvodynia
  32. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus sta...
  33. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Sta...
  34. Early Diagnostics of Vulvar Intraepithelial Neoplasia
  35. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments: A Cross-sectional Study: Erratum
  36. Risk Factors for Positive Margins in High-Grade Cervical Intraepithelial Neoplasia After Transformation Zone Excision
  37. Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review
  38. Wet Mount Microscopy of the Vaginal Milieu Does Not Predict the Outcome of Fertility Treatments
  39. COVID-19 related acute genital ulcer: a case report
  40. The Vaginal Microbiome: I. Research Development, Lexicon, Defining “Normal” and the Dynamics Throughout Women's Lives
  41. The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions
  42. The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
  43. The Vaginal Microbiome: IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers
  44. The Vaginal Microbiome: V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
  45. Vulvar High-Grade Squamous Intraepithelial Lesions and Cancer as a Risk Factor for Anal Cancer: A Review
  46. Use of Moisturizers and Lubricants for Vulvovaginal Atrophy
  47. Hormonal Approach for Postmenopausal Vulvovaginal Atrophy
  48. Genitourinary Syndrome of Menopause: Epidemiology, Physiopathology, Clinical Manifestation and Diagnostic
  49. Surgical treatment for provoked vulvodynia – Where do we stand? A narrative review
  50. G-spot: Fact or Fiction?: A Systematic Review
  51. Superficially Invasive Vulvar Squamous Cell Carcinoma: A 37-Year-Long Experience of a Tertiary Referral Center
  52. Diagnosis of bacterial vaginosis: Clinical or microscopic? A cross‐sectional study
  53. Cytology Is Not Reliable to Evaluate Cervical Disease Regression
  54. Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease
  55. Clinical manifestations and evaluation of postmenopausal vulvovaginal atrophy
  56. For Anal Cancer, Not All Women Are Equal
  57. Clinical validation of a new molecular test (Seegene Allplex™ Vaginitis) for the diagnosis of vaginitis: a cross‐sectional study
  58. Clarification about vulvar cancer precursor lesions
  59. The International Society for the Study of Vulvovaginal Disease Vaginal Wet Mount Microscopy Guidelines: How to Perform, Applications, and Interpretation
  60. Knowledge of Vulvar Anatomy and Self-examination in a Sample of Italian Women
  61. Letter to the editor: “Do variations in labial anatomy have an effect on recurrent urinary tract infection?”
  62. Erosive Vulvar Lichen Planus and Risk of Vulvar Neoplasia
  63. Prognostic factors for recurrence and survival in uncommon variants of vulvar cancer
  64. Cross-Protective IgG and IgA Antibodies against Oncogenic and Non-Oncogenic HPV Genotypes
  65. Impact of a High Coverage Vaccination Rate on Human Papillomavirus Infection Prevalence in Young Women: A Cross-sectional Study
  66. Better studies needed on LASER use in urinary incontinence
  67. Prognostic factors in patients with vulvar cancer: the VULCAN study
  68. Editorial Comment: The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  69. Better triage tests needed for HPV‐positive women
  70. Adult Vulvar Lichen Sclerosus: Can Experts Agree on the Assessment of Disease Severity?
  71. Corrigendum
  72. The International Classification of Diseases, 11th Revision: A Step-Back for Women With Vulvodynia?
  73. Diagnosis of vaginitis: time to improve and move on
  74. Response letter to comments related to “The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document”
  75. Systematic review and meta-analysis of the effects of treatment modalities for vestibulodynia in women
  76. Vulvodynia: a neglected chronic pain diagnosis
  77. Academic cosmetic gynaecology and energy-based therapies: ambiguities, explorations, and FDA advisories
  78. Descriptors of Vulvodynia: A Multisocietal Definition Consensus (International Society for the Study of Vulvovaginal Disease, the International Society for the Study of Women Sexual Health, and the International Pelvic Pain Society)
  79. Impact of the Sampling Site in the Result of Wet Mount Microscopy
  80. The Clinical Role of LASER for Vulvar and Vaginal Treatments in Gynecology and Female Urology: An ICS/ISSVD Best Practice Consensus Document
  81. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document
  82. The energy based devices for vaginal “rejuvenation,” urinary incontinence, vaginal cosmetic procedures, and other vulvo‐vaginal disorders: An international multidisciplinary expert panel opinion
  83. Immediate Loop Electrode Excisional Procedure for High-Grade Cervical Cytology: One Size Fits All?
  84. Vulvodynia: A disease commonly hidden in plain sight
  85. International Society for the Study of Vulvovaginal Disease Recommendations Regarding Female Cosmetic Genital Surgery
  86. To the Editor:
  87. Bioengineering Organs for Blood Detoxification
  88. The ReCiDiF method to treat recurrent vulvovaginal candidosis: A friend with benefits
  89. Diagnosis and management of vulvodynia in postmenopausal women
  90. Aerobic vaginitis: no longer a stranger
  91. Clinical Validation of a Test for the Diagnosis of Vaginitis: Correction
  92. Clinical Validation of a Test for the Diagnosis of Vaginitis
  93. Lichen sclerosus in women: a review
  94. Survey on Aesthetic Vulvovaginal Procedures: What do Portuguese Doctors and Medical Students Think?
  95. Women without vulvodynia can have a positive ‘Q-tip test’: a cross sectional study
  96. P-04-003 Prevalence of Sexually Transmitted Diseases Among Women in Principe Island
  97. Deconstructing the genitourinary syndrome of menopause
  98. Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island
  99. Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504)
  100. Is the DSM-V Leading to the Nondiagnosis of Vulvodynia?
  101. Lipschütz ulcers: should we rethink this? An analysis of 33 cases
  102. Bacterial vaginosis and inflammatory response showed association with severity of cervical neoplasia in HPV-positive women
  103. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities
  104. The “Genitourinary Syndrome of Menopause”
  105. Emphysematous Vaginitis
  106. What Differentiates Symptomatic from Asymptomatic Women with Lichen Sclerosus?
  107. Prevalence of vulvodynia and risk factors for the condition in Portugal
  108. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism
  109. Mycoplasma pneumoniae
  110. Lichen Sclerosus in Breast Cancer Survivor
  111. Ovarian intratumoral 21-hydroxylase deficiency in a postmenopausal hirsute woman
  112. Sclerosing stromal tumour of the ovary associated with Meigs' syndrome and elevated CA125
  113. Case report: intra-partum utero-ovarian vessels rupture
  114. Use of extensible internal device in the femur of young dogs
  115. L-band land mobile satellite (LMS) amplitude and multipath phase modeling in urban areas
  116. Mobile and Base Station Diversity Simulation Experiments in a Mobile Communications Course